Table of Contents
Understanding the nature, formation, detection, and clinical impact of blood group antibodies is important for lab scientists to ensure safe transfusion practices and effective prenatal care.
Blood group antibodies are crucial in clinical labs; they can cause immune reactions ranging from mild delayed hemolysis to fatal acute hemolytic transfusion reactions or hemolytic disease of the fetus and newborn.
What are blood group antibodies?
Blood group antibodies are proteins produced by the immune system that recognize and bind to specific antigens on the surface of red blood cells. People have different antigens based on their genetic makeup.
The immune system forms resistance by producing antibodies after identifying foreign antigens that might have been caused by transfusion, pregnancy, or transplantation. Blood group antibodies involve two main classes of immunoglobulin: IgM and IgG.
- IgM (immunoglobulin M) is the largest antibody molecule in the human immune system. It comprises five monomer units. They are large and do not cross the placenta. They are commonly found in naturally occurring antibodies (e.g, anti-A, anti-B).
- IgG (Immunoglobulin G) is monomeric with two antigen-binding sites. They can cross the placenta, posing a risk for hemolytic disease of the fetus and newborn (HDFN). They are found in immune antibodies formed after sensitization.
Types of blood group antibodies
There are three types of blood group antibodies: naturally occurring antibodies, alloantibodies, and autoantibodies.
- Naturally occurring antibodies
These antibodies are found in the individual’s plasma without exposure to foreign RBC antigens. They are formed through environmental exposure, such as bacterial polysaccharides and plant proteins. These antibodies may be formed after exposure to microorganisms that have structural similarities to human blood group antigens. These antigens are stimulated due to exposure to enteric bacteria; the antigens are anti-A or anti-B. They are typically of the IgM class. Anti-A and anti-B antibodies are formed during infancy at 3-6 months.
2. Alloantibodies
Alloantibodies, also known as immune antibodies, are produced after exposure to foreign red blood cell antigens that are non-self antigens of the same species. Alloantibodies can be clinically significant in future transfusions, potentially causing hemolytic transfusion reactions, making it difficult to find compatible blood, and increasing the probability of causing hemolytic disease of the fetus and newborn.
3. Autoantibodies
An autoantibody is an antibody produced by the immune system that is directed against one or more of the individual’s proteins instead of protecting them from substances that make them sick. Autoantibodies cause diseases such as rheumatoid arthritis, lupus, and type 1 diabetes. In other cases, autoantibodies block the normal signaling pathways of cells, disrupting their function.
ABO blood group system and antibodies
ABO is a very important blood group system. It classifies blood based on the presence or absence of two antigens, A and B, on the surface of red blood cells. The antigens are inherited; therefore, a person’s blood type (A, B, AB, or O) is determined by the combination of the antigens.
Antigens and antibodies
- Antigens: These are proteins found on the surface of red blood cells that can trigger an immune response.
- Antibodies: These are proteins the immune system produces to detect and fight foreign antigens.
Blood group determination
- Type A: People with blood type A have antigen A in their red blood cells and antibodies anti-B in their plasma.
- Type B: People with blood type B have B as the antigen in their red blood cells and anti-A as the antibodies in their plasma.
- Type AB: People with blood type AB have both antigen A and B in their red blood cells and lack antibodies A and B in their plasma.
- Type O: people with blood Type O lack both antigen A and B in their red blood cells, but antibodies A and B are in their plasma.
| Blood type | RBC antigens | Plasma antibodies |
| A | A | Anti-B |
| B | B | Anti-A |
| AB | A and B | None |
| O | none | Anti-A and anti-B |
The ABO system is critical in transfusion medicine of the risk of acute hemolytic transfusion reaction(AHTRs)
ABO compatibility must always be verified before any transfusion.
ABO antibodies in newborns
At birth, infants do not have fully developed ABO antibodies. They begin to form around 3 to 6 months of age making ABO HDFN rare and typically mild compared to Rh HDFN.
Rh blood group system and antibodies
The Rh blood group system is the second most clinically important system after ABO due to its strong immunogenicity and its role in hemolytic transfusion reactions and hemolytic disease of the fetus and newborn (HDFN)
The Rh blood group system is a complex network of antigens, of which the D antigen is the most clinically significant. Individuals are classified as Rh-positive if their red blood cells (RBC) express the D antigen, while those lacking this antigen are designated as Rh-negative.
Beyond the D antigen, other notable components of the Rh system include the C, c, E, and e antigens, each contributing to the richness of this blood group classification.
The gene locus responsible for the Rh antigens is located on chromosome 1, spotlighting its genetic inheritance. Rh antigens are integral protein structures embedded within the RBC membrane, vital in cellular interactions.
Formation of Rh antibodies
Unlike the naturally occurring antibodies of the ABO blood group system, Rh antibodies are not present in the absence of immune sensitization. Such sensitization can occur in specific scenarios, including;
- Receiving blood containing Rh-positive blood by an Rh-negative individual.
- Intrauterine fetal-maternal bleeding during pregnancy, particularly when an Rh-negative mother is carrying an Rh-positive fetus.
The antibodies produced in response to sensitization are predominantly of the IgG class. They have the unique ability to traverse the placental barrier, posing significant clinical implications.
Clinical significance of Rh antibodies
- Hemolytic disease of the fetus and newborn (HFDN): In cases where an Rh-negative mother produces anti-D antibodies, there is a risk that these antibodies will attack the fetal red blood cells in future pregnancies. Severe manifestations of this condition can lead to hydrops fetalis or tragic outcomes such as fetal demise.
- Hemolytic transfusion reactions (HTRs): Administering Rh-positive blood to an Rh-negative patient who has developed anti-D antibodies can provoke delayed hemolytic transfusion reactions, complicating the transfusion process and patient management.
How to prevent the risk of Rh sensitization
Rh immunoglobulin (RhIG) prophylaxis is administered to Rh-negative pregnant women both during pregnancy and after delivery, particularly if the newborn is Rh-positive. This precautionary treatment neutralizes any D-positive fetal cells that may enter the mother’s bloodstream, effectively preventing sensitization. The standard dosage typically administered is 300 µg at 28 weeks of gestation, with an additional dose postpartum if warranted.
Other Rh antibodies
| Antibody | Immunoglobulin class | Clinical significance |
| Anti-C | IgG | HDFN, HTR |
| Anti-c | IgG | HDFN, HTR |
| Anti-E | IgG | HDFN, HTR |
| Anti-e | IgG | Rarely significant |
When transfusions are necessary, Rh antibodies typically necessitate the use of antigen-negative blood to prevent adverse reactions. Their presence is identified through the indirect antiglobulin test (IAT) during routine antibody screenings.
Other clinically significant blood group system antibodies
Besides the well-known ABO and Rh systems, a myriad of other blood group systems exists, each holding potential significance in the context of hemolytic transfusion reactions and HDFN.
Kell blood group antibodies
Ranked as the second most immunogenic blood group system after the Rh D antigen, the Kell system includes key antigens such as K (K1) and K (Cellano). The antibody commonly associated with this system is anti-K, an IgG antibody that can lead to serious complications, including HDFN and HTRs. Even minimal exposure to antigen-positive cells in an Rh-negative individual may trigger alloimmunization, underscoring the importance of careful blood matching.
Duffy blood group antibodies
The Duffy blood group system, which comprises the Fya and Fyb antigens, plays a unique role, particularly as its antigens serve as receptors for the plasmodium vivax malaria parasite. The antibodies associated with this system, Anti-Fya and Anti-fyb (both IgG), may also lead to HDFN and transfusion reactions, further highlighting the clinical relevance of this blood group.
Kidd blood group system antibodies
The Kidd blood group system is defined by its Jka and Jkb antigens, with antibodies including anti-Jka and anti-Jkb (IgG). This system is notorious for causing delayed hemolytic transfusion reactions (DHTRs), as Kidd antibodies can become undetectable between transfusions. Additionally, these antibodies can activate complement, resulting in severe hemolysis.
MNS blood group antibodies
The MNS blood group encompasses the MNS and s antigens. Associated antibodies such as Anti-S, anti-s, and occasionally anti-M (IgG) can play a role in HDFN and HTRs. Notably, Anti-M is frequently found to occur naturally and is typically of the IgM class, though it can also be identified as IgG.
Lewis, Lutheran, and P blood systems antibodies
| System | antigens | Typical antibody | Clinical significance |
| Lewis | Lea, Leb | Usually IgM | Rarely causes HTRs or HDFN |
| lutheran | Lua, Lub | Usually IgG | Occasionally, HDFN or HTRs |
| P system | P1,Pk | Anti-PI (IgM),Anti-PPP1PK (IgG) | Rare but can cause severe reactions |
Detection and identification of blood group antibodies
There are four major methods for identifying blood group antibodies:
- Antibody screening
- Antibody identification
- Antibody titration
- Crossmatching and compatibility testing
Antibody screening
Antibody screening is a routine pre-transfusion test used to detect unexpected red cell antibodies in a patient’s plasma. It helps identify whether a patient has developed alloantibodies(e.g., due to a prior transfusion reaction) if incompatible blood is given.
This is conducted using reagent screening cells that have known antigen profiles. The indirect antiglobulin tests is used.
Patient serum+ reagent red cells → incubation at 37◦C → washing → addition of anti-human globulin (AHG) reagent.
A positive agglutination result signifies the presence of an antibody.
Antibody identification
If the screening test shows a positive result, additional testing is needed to identify the specific antibody:
The patient’s serum is examined against a panel of red cells with established antigen profiles. Advanced techniques like enzyme-treated cells, adsorption/ elution, or genotyping might be required in complex scenarios.
Antibody titration
Titration measures the concentration (strength) of an antibody, which is particularly significant in pregnancies:
Increasing titers of IgG antibodies (for instance, anti-D or anti-K) can indicate the risk of hemolytic disease of the fetus and newborn (HDFN)
Serial titers facilitate monitoring and timely intervention, such as intrauterine transfusions or early delivery.
Crossmatching and compatibility testing
Crossmatching ensures the donor’s RBCs will not react negatively to the recipient’s serum. It is a vital step in pre-transfusion evaluation.
Types of crossmatch:
| Crossmatch type | purpose | Performed when | Detects |
| Immediate spin (IS) | Quick ABO compatibility check | No history of antibodies | ABO incompatibilty |
| Indirect antiglobulin test (IAT) | Full crossmatch | The patient has alloantibodies | Clinically significant IgG antibodies |
| Electronic crossmatch | Computer match of records | No antibodies present | ABO compatibility via verified records |
.
Summary table of blood group antibodies
| Antibody | Type | Ig class | Reacts at | Clinical Risk | Notes |
| Anti-A/B | Natural | IgM | cold | Acute HTR | ABO system |
| Anti-D | Immune | IgG | Warm | HDFN, delayed HTR | Rh (D) system |
| Anti-K | Immune | IgG | Warm | Severe HDFN | Kell system |
| Anti-Fya | Immune | IgG | Warm | Delayed HTR, HDFN | Duffy system |
| Anti-jka | Immune | IgG | Warm | Delayed HTR | Kidd system |
| Anti-S | Immune | IgG | Warm | HTR, HDFN | MNS system |
| Auto-anti-I | Autoimmune | IgM | Cold | Cold agglutinin syndrome | Can interfere with testing |
Final thoughts for lab scientists
Lab scientists play a critical role in transfusion safety and maternal-fetal medicine. Proper detection, identification, and interpretation of blood group antibodies:
- Prevents life-threatening transfusion reactions
- Protect pregnancies from HDFN.
- Guides clinicians in patient care decisions.
- Enhances blood bank operations with safe crossmatching and component selection.
What to do
- Always verify ABO and RH typing, even minor errors can be fatal.
- Investigate all positive antibody screens thoroughly.
- Track antibody histories to aid in selecting antigen-negative units.
- Use antigen typing/genotyping in complex or multi-transfused cases.
- Communicate clearly with physicians and the transfusion team.
